Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding metastasis-directed radiation therapy to standard-of-care chemotherapy improved progression-free ...

Researchers from The University of Texas MD Anderson Cancer Center demonstrated that adding metastasis-directed radiation therapy to standard-of-care chemotherapy improved progression-free ...

MDT has emerged as a major area of research after a successful initial study at MD Anderson in 2016 demonstrated its effectiveness for patients with lung cancer.

After a median follow-up of 17.3 months, the 7.8-month difference in median PFS favoring MDT translated into a statistically significant 57% reduction in the hazard ratio for progression or death ...

ICON shares results of a survey of over 100 oncology drug development professionals on the current state of emerging oncology treatment development.